Health claim
“Senolytic drug dasatinib combined with quercetin can clear senescent cells and improve physical function in older adults.”
Claim checked — mixed / earlyHigh riskmedications
Evidence Summary
Some evidence supports this, but findings are inconsistent or limited in scope.
Early small-scale human studies show dasatinib plus quercetin can reduce senescent cell markers and modestly improve physical performance, but findings are limited and not yet consistently replicated.
Extracted from
333 ‒ Longevity roundtable—the science of aging, geroprotective molecules, & lifestyle interventionsPeter Attia MD
A roundtable discussion featuring Peter Attia and three experts examines current scientific understanding of aging, potential geroprotective compounds, and lifestyle strategies for longevity.
Watch breakdown →